the head of plasma donor safety at CSL Plasma, one of the world's largest plasma collectors. "Human plasma is used to produce therapies that treat diseases such as primary immune deficiencies ...

According to analysts at Fortune Business Insights, two-thirds of these centers are owned by one of three companies: CSL Plasma, Grifols, and BioLife. Even before the pandemic hit, global demand ...

A Miami man is facing a charge of attempted murder after he allegedly stabbed a 47-year-old in the neck at a plasma donation ...

This blue chip is releasing its eagerly anticipated results next week. Here's what to expect. The post Own CSL shares? Here's ...

which is now known as global biotechnology leader CSL Behring; US plasma collector Nabi, which helped to form the world’s premier plasma collection company in CSL Plasma; the Novartis influenza ...

If it goes through, the merger will allow CSL to diversify its business which is focused mainly on plasma-derived medicines sold by its CSL Behring unit and vaccines under the Seqirus arm ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved CSL’s Andembry (garadacimab) to prevent ...

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on CSL (CMXHF – Research Report) on January 29 and set a price target of A$286.00.

The even better news is that the general consensus is that CSL stock could generate big returns over the next 12 months. Let's look at what a few brokers are saying about the plasma therapies leader.

Here's how I would go about building a winning portfolio this year (and every other year). The post How to build a ...